fbpx

Quarterly Newsletter

  • What is the Structure to Canada’s Legalization of Marijuana?

    (December 14, 2018)

    (Winter 2018) Canada’s marijuana legalization has taken a different form than in the United States. In many ways, it’s inverse. For example, U.S. legalization is largely state-driven and technically illegal at the federal level. In Canada, the feds are spurring on the change. This countrywide acceptance means marijuana can be bought and sold across provincial […]

    Read More
  • Disability Concerns Gain Focus in Regard to Medical Marijuana Legalization

    (December 14, 2018)

    (Winter 2018) United States District Judge Jeffrey Meyer handed down the first federal court ruling in favor of state medical marijuana legislation over the federal ban. This could set precedent for other cases throughout the nation. The case involved Katelin Noffsinger, who learned that her job offer from a company in Connecticut was pulled after […]

    Read More
  • OSHA Clarifies Its Stance on Drug Testing

    (December 14, 2018)

    (Winter 2018) In October, the Substance Abuse Program Administrators Association (SAPAA) sent a notification to its members (including Working Partners®) about a recent OSHA memo. Below is the message they shared. “On October 11, 2018, the Occupational Safety and Health Administration (OSHA) of the U.S. Department of Labor, published a Memorandum to its Regional Administrators and […]

    Read More
  • Clarifying the Legality of CBD

    (December 14, 2018)

    (Winter 2018) You may be seeing CBD items widely for sale in Ohio, but do not be fooled. CBD sales are still illegal in the Buckeye State, except by an establishment licensed as a Medical Marijuana Control Program dispensary. In October the Ohio Board of Pharmacy issued a statement to this effect to clarify the […]

    Read More
  • Trump Signs the SUPPORT for Patients and Communities Act

    (December 14, 2018)

    (Winter 2018) In late October President Trump approved a set of about 70 measures called the SUPPORT Act (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act). This Legislation package includes verbiage that will permit nurse midwives, nurse anesthetists and clinical nurse specialists to write buprenorphine prescriptions for individuals addicted […]

    Read More
  • Canada: Second Country to Legalize Marijuana. What’d They Do to Get Here?

    (December 14, 2018)

    (Winter 2018) Uruguay gave the nod to marijuana in 2013, and Canada, our neighbor to the north, just began recreational marijuana sales in October. Canadian residents aged 18 or older are now legally permitted to carry approximately one ounce of the substance. They are also entitled to raise as many as four marijuana plants at […]

    Read More
  • Impact to Ohio from the Recent Bill Signed by Trump

    (December 14, 2018)

    (Winter 2018) Just over a week before election day, legislators in the Buckeye State announced that close to $56 million was allocated by the federal government to fight Ohio’s opioid crisis. The funding is earmarked for a State Opioid Response Grant and will go toward increasing access to medication-assisted therapies raising awareness among Ohioans regarding […]

    Read More
  • Workplace Relevance of the SUPPORT for Patients and Communities Act

    (December 14, 2018)

    (Winter 2018) Employers may also see changes due to the SUPPORT for Patients and Communities Act. There is a high probability that the Mandatory Guidelines for Federal Workplace Drug Testing Programs will be revisited by the Secretary of Health and Human Services (HHS) to decide if the opioid category should be widened to incorporate fentanyl. […]

    Read More
  • Crackdown on “Dark Web” Dealers

    (September 21, 2018)

    (Fall 2018) The Drug Enforcement Administration’s (DEA) reclassification of opioids like hydrocodone and oxycodone from Schedule III to Schedule II impacted how physicians prescribe these substances.  One consequence of the classification change is that more opioids are being sold on the internet at covert sites called the “dark web” or “darknet.” Analysis of dark web […]

    Read More

DISCLAIMER: This publication is designed to provide accurate information regarding the subject matter covered. It is provided with the understanding that those involved in the publication are not engaged in rendering legal counsel. If legal advice is required, the services of a competent professional should be sought.